Press release
Europe to hold The major Piece of Cake in the Addison's Disease Therapeutics Market between 2020 and 2030
Addison’s disease is a hormonal disorder characterized by inadequate secretion of certain hormones such as cortisol (glucocorticoid) and aldosterone (mineralocorticoid) by adrenal gland. Cortisol manages glucose level and is also helpful in suppressing immune response. Aldosterone regulates the sodium and potassium level in the body. This disease condition is also called as adrenal insufficiency and occurs in people of all age groups. Addison’s disease affects both sexes equally. In some cases it can be life threatening as well. This disease is mainly caused by damage to the adrenal cortex that may be due to autoimmune disorders including chronic thyroiditis, Graves’ disease, myasthenia gravis and pernicious anemia; infectious diseases such as tuberculosis, HIV and fungal infections; tumor and hemorrhage into the adrenal gland. In major developed countries, tuberculosis has been identified as one of the major factors for Addison’s disease and accounts for nearly 20% of all adrenal insufficiency cases. Most common symptoms associated with this hormonal disorder include weight loss, tiredness, loss of appetite, muscle weakness, low blood pressure, paleness, chronic diarrhea, nausea, vomiting and darkening of the skin in some places.To remain ‘ahead’ of your competitors, request for a sample here@ https://www.persistencemarketresearch.com/samples/19741
Addison’s disease is usually diagnosed by a blood test (for potassium level, cortisol level and serum sodium) or CT scan. In some cases abdominal X-ray is also performed in order to confirm the illness. Its treatment involves the replacing of insufficient hormones with the laboratory developed hormones that mimic the functions of natural ones. Hydrocortisone tablet is given orally in order to replace cortisol while fludrocortisone acetate is recommended for aldosterone insufficiency. The market for Addison’s disease therapeutics is primarily dominated by generic drugs such as cortisone, fludrocortisones and prednisone whose patent exclusivity had expired since long.
The market for Addison’s disease therapeutics is expected to grow worldwide owing to globally rising incidence of Addison’s disease and rigorous research and development leading to introduction of new products. According to sources from Elsevier, Inc., the annual incidence rate of Addison’s disease has been found 5-6 per million of population while the prevalence rate is 40-110 per million of population. A recent epidemiological study indicates that the incidence of Addison’s disease is increasing year on year. In September 2012, ViroPharma, Inc. launched a novel drug called Plenadren in Denmark for treating adrenal insufficiency. This novel drug was granted a European marketing Authorization by the European Commission in November 2011. Denmark became the first country in the whole European Union to offer a new treatment option to people suffering from Addison’s disease in over the last 50 years. Increasing awareness among patients and physicians regarding the disease is also expected to play a key role in driving the market growth during the forthcoming years.
Request for Table of Content (TOC) @ https://www.persistencemarketresearch.com/toc/19741
In terms of geography, the market for Addison’s disease therapeutics has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). Reimbursement of expenses related with the Addison’s disease treatment by Medicare and Medicaid in the United States is one of the major factors driving the market growth in the North American region. Also the fact that patients and physicians of this region being more aware than the patients and physicians of other regions is driving the market growth in the region. Some of the major research institutes and companies engaged in the development, manufacturing and marketing of drugs and injectables for the Addison’s disease treatment are University of Wurzburg, Aarhus University, Oregon Health and Science University, University Hospital Tubingen, Shire plc, DuoCort AB and HaEmek Medical Center.
Contact Us:
305 Broadway
7th Floor
New York City, NY 10007
United States
U.S.A - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PersistenceMarketResearch.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Europe to hold The major Piece of Cake in the Addison's Disease Therapeutics Market between 2020 and 2030 here
News-ID: 2206747 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Addison’s
Addison’s Disease Therapeutics Market Significantly Stepping towards the Succe …
Addison's disease, commonly known as adrenal insufficiency, is a rare ailment in which your body fails to create enough hormones. Your adrenal glands, which are placed directly above your kidneys, produce too little cortisol and, in some cases, too little aldosterone in Addison's disease.
Request Sample Copy of Addison’s Disease Therapeutics Market Report: https://www.infinitybusinessinsights.com/request_sample.php?id=608756
Top Key Players Included in Addison’s Disease Therapeutics Market Report:
Bristol-Myers Squibb
Merck
Novartis
Pfizer
Takeda Pharmaceutical
Bio-Techne
GlaxoSmithKline
Lupin Pharmaceuticals
Abbott
Amgen
Bayer
Biogen
Eli Lilly and Company
Boehringer Ingelheim International
Diurnal
Switzer…
Addison’s Disease Market Trends 2021 | Segmentation, Outlook, Industry Report …
The global Addison’s Disease Market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The growth of the market is mainly attributed to the increase in the prevalence of Addison’s disease, rising R&D activities to produce new drugs for diagnosis and increasing awareness about Addison’s disease among the population across the globe. The advancement in technologies and several government initiatives also played a vital role in…
Global Addison’s Disease Drugs Industry Professional Market Analysis by 2020-2 …
This report also researches and evaluates the impact of Covid-19 outbreak on the Addison’s Disease Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Addison’s Disease Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Global Addison’s Disease Drugs Market Overview:
GLOBAL INFO RESEARCH has evaluated the global Addison’s Disease Drugs market in its latest research report. The research report,…
Addison’s Disease Treatment Market: Global Markets & Advanced Technologies
Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some…
Addison’s Disease Treatment Market Latest Trends & Insights 2024
Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some…
Addison’s Disease Treatment Market : Trends, Opportunities and Forecasts 2024
Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some…